Pineapple Express Cannabis (PNXP) EBITDA Margin (2018 - 2024)

Pineapple Express Cannabis has disclosed EBITDA Margin across 6 years of filings, most recently posting 28.81% for Q4 2024.

• EBITDA Margin for Q4 2024 came in at 28.81%, changed N/A year-over-year; the trailing twelve-month figure through Jul 2025 was 15239.34% (down 1516084.0% YoY), and the FY2025 annual result was 104.26%, changed N/A from the prior year.
• EBITDA Margin came in at 28.81% for Q4 2024 at Pineapple Express Cannabis, down from 43.48% in the prior quarter.
• In the past five years, EBITDA Margin ranged from a high of 546.58% in Q1 2021 to a low of 1684.78% in Q1 2022.
• The 4-year median for EBITDA Margin is 3.87% (2020), against an average of 151.55%.
• Across the five-year window, EBITDA Margin jumped 18125 bps in 2021 and sank 223136 bps in 2022, its largest moves.
• Pineapple Express Cannabis' EBITDA Margin stood at 21.07% in 2020, then surged by 87 bps to 39.5% in 2021, then tumbled by 1398 bps to 512.79% in 2022, then jumped by 94 bps to 28.81% in 2024.
• The last three EBITDA Margin figures came in at 28.81% (Q4 2024), 43.48% (Q3 2024), and 184.11% (Q2 2024), per Business Quant data.